STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGL
  4. [Form 4] agilon health, inc. Insider Trading Activity

agilon health (AGL) director granted 2,133-share RSU award, now holds 8,207 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

McLoughlin Karen reported acquisition or exercise transactions in this Form 4 filing.

agilon health, inc. director Karen McLoughlin reported receiving an equity award of 2,133 shares of common stock in the form of restricted stock units. These units vest in full on June 2, 2027, if she continues serving as a director through that date.

After giving effect to a 1-for-25 reverse stock split effective March 30, 2026, her beneficial ownership, including restricted stock units, totals 8,207 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider McLoughlin Karen
Role null
Type Security Shares Price Value
Grant/Award Common Stock 2,133 $0.00 --
Holdings After Transaction: Common Stock — 8,207 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Includes restricted stock units.
RSU grant size 2,133 shares Restricted stock units granted on June 2, 2026
Post-transaction holdings 8,207 shares Beneficial ownership including RSUs after transaction
Grant price $0.0000 per share Equity compensation, not a market purchase
Reverse stock split ratio 1-for-25 Effective March 30, 2026 for common stock
RSU vesting date June 2, 2027 Units vest in full subject to continued service
restricted stock units financial
"Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
reverse stock split financial
"reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026."
A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.
beneficially owned financial
"The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
equity compensation financial
"Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director."
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McLoughlin Karen
(Last)(First)(Middle)
C/O AGILON HEALTH, INC.
440 POLARIS PARKWAY, SUITE 550
(Street)
WESTERVILLE OHIO 43082
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026A2,133(1)A$08,207(2)(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director.
2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
3. Includes restricted stock units.
Remarks:
/s/ Mimi Yang, as Attorney-in-Fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did agilon health (AGL) director Karen McLoughlin report on this Form 4?

Karen McLoughlin reported receiving 2,133 shares of agilon health common stock as a restricted stock unit award. The grant is compensation for board service and is not an open-market stock purchase or sale.

When do Karen McLoughlin’s agilon health (AGL) restricted stock units vest?

The restricted stock units vest in full on June 2, 2027, if she continues to serve as a director. This means the entire 2,133-share award becomes unrestricted on that date, assuming service conditions are met.

How many agilon health (AGL) shares does Karen McLoughlin own after this transaction?

Following the award, Karen McLoughlin beneficially owns 8,207 shares of agilon health common stock, including restricted stock units. This figure reflects adjustments from the company’s 1-for-25 reverse stock split effective March 30, 2026.

Was Karen McLoughlin’s agilon health (AGL) equity award affected by a reverse stock split?

Yes. The reported post-transaction beneficial ownership of 8,207 shares reflects agilon health’s 1-for-25 reverse stock split effective March 30, 2026. Both existing holdings and awards were adjusted to account for the reverse split.

Is this agilon health (AGL) Form 4 a stock purchase or sale by Karen McLoughlin?

No. The Form 4 reports a grant of restricted stock units with a zero dollar price per share. It represents equity-based compensation for board service, not an open-market purchase or sale of agilon health stock.